Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia

IL-2 is a natural, T cell–derived cytokine that stimulates the cytotoxic functions of T and natural killer cells. IL-2 monotherapy has been evaluated in several randomized clinical trials (RCTs) for remission maintenance in patients with acute myeloid leukemia (AML) in first complete remission (CR1)...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Buyse, Marc, Squifflet, Pierre, Lange, Beverly J., Alonzo, Todd A., Larson, Richard A., Kolitz, Jonathan E., George, Stephen L., Bloomfield, Clara D., Castaigne, Sylvie, Chevret, Sylvie, Blaise, Didier, Maraninchi, Dominique, Lucchesi, Kathryn J., Burzykowski, Tomasz
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Society of Hematology 2011
विषय:
Clinical Trials and Observations
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3539044/
https://ncbi.nlm.nih.gov/pubmed/21518931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-02-337725
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन